Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GM-CSF and Ipilimumab as Therapy in Metastatic Melanoma, a Phase II Study

NCT01363206 is registered in ClinicalTrials.gov with Lynn E. Spitler, MD as lead sponsor.

NCT NCT01363206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01363206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GM-CSF and Ipilimumab as Therapy in Metastatic Melanoma, a Phase II Study
Lead sponsor
Lynn E. Spitler, MD
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2011
Completion date
May 31, 2015
Enrollment
29 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma, metastatic